Literature DB >> 17062977

Differential myolysis of myocardium and skeletal muscle in hamsters with dilated cardiomyopathy: beneficial protective effect of diltiazem.

Yosuke Kato1, Mitsunori Iwase, Kenji Takagi, Takao Nishizawa, Hiroaki Kanazawa, Aya Matsushita, Hisashi Umeda, Hideo Izawa, Akiko Noda, Yasuo Koike, Kohzo Nagata, Mitsuhiro Yokota.   

Abstract

BACKGROUND: Although dilated cardiomyopathic hamsters (TO-2) with mutation of the delta-sarcoglycan gene exhibit histological features of muscular dystrophy, it remains to be elucidated whether both myocardium and skeletal muscle are injured in a similar manner. METHODS AND
RESULTS: The progression of myolysis in both myocardium and skeletal muscle were assessed biochemically and pathologically in TO-2 and F1B control hamsters. Left ventricular (LV) function was assessed by echocardiography and cardiac catheterization. Both the plasma concentration of cardiac troponin T and the plasma activity of alpha-hydroxybutyrate dehydrogenase (HBD) peaked at 8 weeks of age, and thereafter reduced greatly in TO-2 hamsters. Activity of creatine kinase (CK) in TO-2 hamsters was significantly greater than in controls throughout the observation period. Pathological findings of both nuclear chain and central nuclei in skeletal muscles were observed in TO-2 hamsters throughout the observation period, suggesting regeneration. LV dysfunction was first evident at 8 weeks of age and deteriorated thereafter in TO-2 hamsters. Treatment of TO-2 hamsters with diltiazem from 5 to 8 weeks of age could avert the LV functional deterioration and the increment in alpha-HBD activity, but CK activity was unchanged.
CONCLUSIONS: Despite myolysis in skeletal muscle occurring consistently throughout the observation period, cardiac myolysis occurred predominantly in the early phase. These initial cardiac events might involve coronary spasm and/or calcium overload in the myocardium.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17062977     DOI: 10.1253/circj.70.1497

Source DB:  PubMed          Journal:  Circ J        ISSN: 1346-9843            Impact factor:   2.993


  6 in total

1.  Activation of host tissue trophic factors through JAK-STAT3 signaling: a mechanism of mesenchymal stem cell-mediated cardiac repair.

Authors:  Arsalan Shabbir; David Zisa; Huey Lin; Michalis Mastri; Gregory Roloff; Gen Suzuki; Techung Lee
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-09-17       Impact factor: 4.733

2.  Activation of Toll-like receptor 3 amplifies mesenchymal stem cell trophic factors and enhances therapeutic potency.

Authors:  Michalis Mastri; Zaeem Shah; Terence McLaughlin; Christopher J Greene; Leah Baum; Gen Suzuki; Techung Lee
Journal:  Am J Physiol Cell Physiol       Date:  2012-07-25       Impact factor: 4.249

3.  Hemodynamic alterations in the coronary circulation of cardiomyopathic hamsters: age and Ang II-dependent mechanisms.

Authors:  Nelson Escobales; Jose A Ramos; Guido E Santacana; Maria J Crespo
Journal:  J Card Fail       Date:  2009-08-20       Impact factor: 5.712

4.  Muscular dystrophy therapy by nonautologous mesenchymal stem cells: muscle regeneration without immunosuppression and inflammation.

Authors:  Arsalan Shabbir; David Zisa; Merced Leiker; Curtis Johnston; Huey Lin; Techung Lee
Journal:  Transplantation       Date:  2009-05-15       Impact factor: 4.939

5.  Gait disturbances in dystrophic hamsters.

Authors:  Thomas G Hampton; Ajit Kale; Ivo Amende; Wenlong Tang; Scott McCue; Hemmi N Bhagavan; Case G VanDongen
Journal:  J Biomed Biotechnol       Date:  2011-01-13

6.  Developmental Changes in the ECG of a Hamster Model of Muscular Dystrophy and Heart Failure.

Authors:  Thomas G Hampton; Ajit Kale; Scott McCue; Hemmi N Bhagavan; Case Vandongen
Journal:  Front Pharmacol       Date:  2012-05-18       Impact factor: 5.810

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.